TCT-565 Continuing Dual Antiplatelet Therapy or Not Did Not Influence the Rate of Major Cardiac and Cerebral Adverse Events (MACCE) When Patients Were Free from MACCE during the First Two Years after Everolimus-eluting Stent Implantation

Authors :: Ken Kurihara
Taro Sasaoka
Yu Hatano
Shunji Yoshikawa
Mitsuaki Isobe
Daisuke Ueshima
Takashi Ashikaga
Source :: Journal of the American College of Cardiology. 66(15)
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: medicine.medical_specialty
business.industry
Everolimus eluting stent
Internal medicine
medicine
Cardiology
business
Adverse effect
Cardiology and Cardiovascular Medicine
Surgery

Full Text Access

Tools